Marché de la virologie – Tendances et analyse de la croissance | Année de prévision 2031

  • Report Code : TIPRE00006886
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 227
Buy Now

Le marché de la virologie devrait atteindre 5 276,48 millions de dollars US d'ici 2028 contre 4 108,27 millions de dollars US en 2021 ; il devrait enregistrer un TCAC de 3,6 % de 2021 à 2028.La virologie fait partie des sections importantes du système de santé. Il a une application étendue dans le développement de vaccins, les diagnostics, les thérapies de traitement et autres. Les acteurs du marché de la virologie sont constamment impliqués dans les innovations et les développements de produits pour soutenir la concurrence sur le marché. Ils explorent différents champs d'innovation produits. Par exemple, pour le COVID-19, les acteurs du marché investissent considérablement dans le développement de vaccins, de kits de test et d'autres produits et services connexes. Vous trouverez ci-dessous quelques-uns des développements du marché liés au marché de la virologie.
  • En août 2021, la Food and Drug Administration (FDA) des États-Unis a approuvé le premier vaccin COVID-19 connu sous le nom de Pfizer-BioNTech Vaccin contre le covid-19. Il sera commercialisé sous le nom de ComiRNAty (Koe-mir’-na-tee). Le vaccin est destiné à prévenir la maladie COVID-19 chez les personnes âgées de 16 ans et plus. Il est également disponible sous autorisation d'utilisation d'urgence (EUA).

  • En avril 2021, CerTest Biotec a lancé son test de diagnostic COVID-19 marqué CE pour le système BD MAX.

  • En mai 2020, Bio-Rad a reçu l'approbation de la FDA pour l'autorisation d'utilisation d'urgence pour le test d'anticorps totaux COVID-19.

  • En mai 2020, Aalto Bio Reagents a lancé de nouvelles protéines de pointe eucaryotes recombinantes SARS-CoV-2 S1-S2.


Ainsi, une telle participation active des acteurs du marché à travers des innovations de produits et le soutien des gouvernements dans différents pays renforce la croissance du marché de la virologie.Régions lucratives pour le marché de la virologie Aperçu du marchéL'adoption croissante de procédures esthétiques mini-invasives et non invasives stimule la croissance du marché de la virologieDes virus tels que le virus de l'immunodéficience humaine (VIH), le virus de la grippe, le virus zika, le virus Ebola, le SRAS-CoV-2 et le virus de la polio infectent une grande population à travers le monde. Comme le virus mute et évolue continuellement, la résistance aux médicaments devient un défi majeur dans la gestion des infections virales chez les humains et les animaux. Un virus se transmet par différents médias en fonction de son type. Par exemple, certains virus provoquent des maladies virales respiratoires, telles que la grippe, le rhume et l'infection par le virus respiratoire syncytial, et ils sont transmis par des gouttelettes générées par la toux ou les éternuements, tandis que certaines maladies virales gastro-intestinales sont transmises par contact direct avec les matières fécales des personnes infectées. personnes ou par des aliments ou de l'eau contaminés. Selon les statistiques mondiales de l'ONUSIDA sur le VIH et le sida, plus de 37,7 millions de personnes dans le monde ont été infectées par le VIH en 2020.Le Comité international sur la taxonomie des virus (ICTV) a déclaré le nouveau coronavirus qui a causé le COVID- 19 sous le nom de coronavirus 2 du syndrome respiratoire aigu sévère (SRAS-CoV-2) en février 2020. Le virus a subi plusieurs mutations depuis son apparition, ce qui a aggravé la gravité de la pandémie de COVID-19. Par exemple, selon les données de suivi COVID-19 des Centers for Disease Control and Prevention (CDC), en août 2021, le taux de cas sur sept jours pour 100 000 est de 299,4 et plus de 164 952 nouveaux cas sont signalés aux États-Unis. De plus, selon le Centre européen de prévention et de contrôle des maladies, en août 2021, le nombre total de cas de COVID-19 atteignait environ 36 307 572 patients dans l'Espace économique européen (EEE). Ainsi, une telle prévalence croissante d'infections virales est à l'origine de la croissance du marché de la virologie.Insights basés sur le typeSelon le type, le marché de la virologie est segmenté en tests de diagnostic, techniques de contrôle des infections virales, thérapeutiques antivirales et interférons. En 2021, le segment des tests de diagnostic devrait détenir la plus grande part du marché, et le segment des techniques de contrôle des infections virales devrait enregistrer le TCAC le plus élevé de 2021 à 2028. Marché de la virologie, par produit (2021 et 2028) Application-Based InsightsSur la base de l'application, le marché est segmenté en infections de la peau et des tissus mous, infections des voies respiratoires, infections des voies gastro-intestinales, maladies sexuellement transmissibles, infections des voies urinaires et autres. En 2021, on estime que le segment des infections des voies respiratoires détient la plus grande part du marché, et il devrait enregistrer le TCAC le plus élevé de 2021 à 2028. Aperçus stratégiquesLes entreprises opérant sur le marché de la virologie mettent l'accent sur adopter la stratégie d'innovations de produits pour répondre à l'évolution des demandes des clients à travers le monde, ce qui leur permet également de maintenir leur marque sur le marché mondial.Marché de la virologie - SegmentationPar type
  • Test de diagnostic
    • Test de virus ADN

    • Test de virus ARN
    • Autres



  • Techniques de contrôle des infections virales
    • Prophylaxie active

    • Prophylaxie passive


    < /li>
  • Thérapeutiques antivirales
    • Agents virucides

    • Agents antiviraux

    • Immunomodulateurs



  • Interférons< span class="MsoCommentReference">


Par application
  • Infections de la peau et des tissus mous

  • Infections des voies respiratoires

  • < li>Infections du tractus gastro-intestinal
  • Maladies sexuellement transmissibles

  • Infections des voies urinaires

  • Autres


Par utilisateur final
  • Hôpitaux

  • Laboratoires de diagnostic

  • Entreprises pharmaceutiques et biotechnologiques

  • Instituts de recherche et universitaires


Par géographie
  • Amérique du Nord
    • États-Unis

    • Canada

    • Mexique


    • Europe
      • France

      • Allemagne

      • Italie

      • Royaume-Uni

      • Espagne< /li>
      • Reste de l'Europe



    • Asie-Pacifique
      • Chine

      • Inde

      • Corée du Sud

      • Japon

      • Australie

      • Reste de l'APAC



    • Moyen-Orient et Afrique
      • Afrique du Sud

      • Arabie saoudite

      • EAU

      • Reste de la MEA



    • Amérique du Sud et centrale < ul>
    • Brésil

    • Argentine

    • Reste de l'arnaque




Profils d'entreprise
  • Abbott

  • Johnson & Johnson Services, Inc.

  • < li>F. Hoffmann-LA Roche Ltd.
  • Thermo Fisher Scientific, Inc.

  • Qiagen

  • < li>Illumina, Inc.
  • Siemens AG

  • GlaxoSmithKline Plc

  • < li>Gilead Sciences, Inc.
  • AbbVie, Inc.les noms de droits d'auteur indiqués sur les sites Web respectifs.

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is Virology?

Virology is a detailed study of viruses that focuses on the structure, classification, evolution, and genetics of viruses. The virology market caters to the prevention and development of treatments for several viral diseases. The increasing prevalence of emerging infectious diseases (EIDs)—chikungunya, Ebola, West Nile virus, severe acute respiratory syndrome (SARS), and Lyme disease is driving the growth of the virology market. The key driving factors for the market growth are, rising prevalence of viral infections and other infectious diseases along with growing awareness about diagnosis and treatment of the disease.

What are the factors impacting for the virology market?

The factors that are driving and restraining factors that will affect virology market in the coming years. Factors such as rising prevalence of viral infectious diseases and increasing product launches, are driving the market growth. However, availability of alternative products and high cost of production of products are likely to hamper the growth of the market.

Who are the major players in the virology market?

The virology market majorly consists of the players such as Abbott, Johnson & Johnson Services, Inc., F. Hoffmann-LA Roche Ltd., Thermo Fisher Scientific, Inc., Qiagen, Illumina, Inc., Siemens AG, GlaxoSmithKline Plc, Gilead Sciences, Inc., and AbbVie, Inc. are amongst others.

What is the market value of virology market based on region?

The global virology market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. North America dominates the global virology market due to factors such as technological advancement, increasing product launches, and increasing investment in healthcare and research. The transmission of infectious diseases globally has made diagnosis mandatory for travelers. Today, the diseases are spreading faster around the world, which is further bolstering the demand for diagnostic tools as they can help control the outbreak at an early stage. For instance, in September 2019, the FDA approved OraQuick Ebola Rapid Antigen Test, a new rapid diagnostic test for Ebola in the US.

Asia Pacific is expected to be the fastest growing region Asia Pacific is expected to expand at a high growth rate due to large patient population, increasing government support to provide better healthcare services, and increasing product launches by market players. For instance, in 2018, Cepheid initiated the HBDC Access Program1 for the diagnosis of HIV, viral hepatitis (HCV), and human papillomavirus (HPV)2 at a relatively lower price. The company is aiming to make tests that would be more accessible to lower-income countries.

Which is the most influencing segment growing in the virology market report?

The global virology market based on based on type is segmented into diagnostic test, viral infection controlling techniques, antiviral therapeutics, and interferons. In 2021, Antiviral Therapeutics segment is estimated to account for the largest market share in the global virology market. the growth can be attributed to increasing prevalence of human immunodeficiency virus (HIV) and increasing research and development investment by private and public companies for antiviral drugs.

The List of Companies - Virology Market

  1. Abbott
  2. Johnson And Johnson Services, Inc.
  3. F. HOFFMANN-LA ROCHE LTD.
  4. THERMO FISHER SCIENTIFIC INC.
  5. QIAGEN
  6. Illumina, Inc.
  7. Siemens AG
  8. Glaxosmithkline Plc
  9. Abbvie Inc.
  10. Gilead Sciences, Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports